Biopharmaceuticals Market Research Reports & Industry Analysis
Biopharmaceuticals are a class of drugs produced using living organisms or their cellular components to treat various medical conditions. By providing highly targeted and sophisticated therapeutic options, biopharmaceuticals have revolutionized the field of medicine. If you are in search of comprehensive and objective data on this fast-growing market, you have come to the right place. MarketResearch.com offers hundreds of biopharmaceuticals industry reports published by leading research firms.
New Biopharmaceuticals Market Research
- Use our reports to explore diverse markets in the biopharmaceuticals industry, from biosimilars to enzymes to antibodies.
- Gain invaluable insights, including biopharmaceuticals market size, growth, and industry trends.
- Get up to speed on the latest technological breakthroughs, opportunities, and market-entry strategies.
Proven Expertise in the Field of Market Research
With a track record spanning more than two decades, MarketResearch.com is a trusted source for market research. We serve top-tier investment banks, management consulting firms, and Fortune 500 multinational corporations. Our dedicated research specialists are here to provide recommendations and guidance throughout your research process. Improve your knowledge and enhance your strategies with biopharmaceutical market research from MarketResearch.com today.
Biopharmaceuticals Industry Research & Market Reports
-
Biosimilar Monoclonal Antibodies Market Size, Trends, Analysis, and Outlook By Product (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab, Others), By Application (Oncology, Chronic & Autoimmune Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Biosimilar Monoclonal Antibodies market size is poised to register 20.64% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biosimilar Monoclonal Antibodies market ... Read More
-
Cell Therapy Human Raw Materials Market Size, Trends, Analysis, and Outlook By Product(Cell Culture Media, Cell Culture Sera, Cell Culture Supplements (Proteins, Growth Factors, Nucleotides, Other Supplements), Reagents & Buffers, Other Raw Materials)By End-user(Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutions), by Region, Country, Segment, and Companies, 2024-2030
... Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutions), by Region, Country, Segment, and Companies, 2024-2030 The global Cell Therapy Human Raw Materials market size is poised to register 25.27% growth from 2024 to 2030, ... Read More
-
Pharmaceutical Market Size, Trends, Analysis, and Outlook By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules), Pharmaceutical Product, Branded, Generic), By Type (Prescription, OTC, Pharmaceutical Disease, Cardiovascular diseases, Cancer, Diabetes, Infectious diseases, Neurological disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Age group (Children & Adolescents, Adults, Geriatric), By End-user (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By ... Read More
-
Rare Diseases Treatment Market Size, Trends, Analysis, and Outlook By Therapeutic Area (Cancer, Neurological Conditions, Cardiovascular Conditions, Musculoskeletal Conditions, Hematologic Disorders, Infectious Diseases, Metabolic Diseases, Endocrine Disorders, Others), By Route of Administration (Oral, Injectable, Others), By Drug Type (Biologics, Biosimilar, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... By Drug Type (Biologics, Biosimilar, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Rare Diseases Treatment market size is poised to register 12.13% growth ... Read More
-
Global Erythropoietin (EPO) Drugs Market Growth 2024-2030
... market, the Erythropoietin (EPO) Drugs is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.4% during review period. The research report highlights the growth potential of the global ... Read More
-
Cell Therapy Raw Materials Market Size, Trends, Analysis, and Outlook By Product (Media, Sera, Cell Culture Supplements, Antibodies, Reagents & Buffers, Others), By End-User (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Others), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Cell Therapy Raw Materials market size is poised to register 24.26% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Rheumatoid Arthritis Therapeutics Market Size, Trends, Analysis, and Outlook By Pharmaceuticals Molecule (NSAIDs, Analgesics, DMARDs, Glucocorticoids), By Biopharmaceuticals Molecule (Biologics, Biosimilars), By Sales Channel (Prescription, Over-the-Counter), by Region, Country, Segment, and Companies, 2024-2030
... Rheumatoid Arthritis Therapeutics market size is poised to register 4.95% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Rheumatoid Arthritis Therapeutics market ... Read More
-
Large and Small-Scale Bioprocessing Market Size, Trends, Analysis, and Outlook By Scale (Industrial Scale, Small Scale), By Workflow (Downstream Processing, Fermentation, Upstream Processing), By Product (Bioreactors/Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags & Containers, Others), By Application (Biopharmaceuticals, Speciality Industrial Chemicals, Environmental Aids), By Use (Multi-Use, Single-Use), By Mode (In-House, Outsourced), by Region, Country, Segment, and Companies, 2024-2030
... Containers, Others), By Application (Biopharmaceuticals, Speciality Industrial Chemicals, Environmental Aids), By Use (Multi-Use, Single-Use), By Mode (In-House, Outsourced), by Region, Country, Segment, and Companies, 2024-2030 The global Large and Small-Scale Bioprocessing market size is poised ... Read More
-
Biopharmaceutical CMO and CRO Market Size, Trends, Analysis, and Outlook By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars), by Region, Country, Segment, and Companies, 2024-2030
... and CRO market size is poised to register 6.11% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biopharmaceutical CMO and CRO market ... Read More
-
Pharmaceutical Regulatory Affairs Market Size, Trends, Analysis, and Outlook By Services (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Others), By Drugs (Innovator, Generics), By Biologics (Biotech, ATMP, Biosimilars), By Indication (Oncology, Neurology, Cardiology, Immunology, Others), By Product Stage (Preclinical, Clinical studies, PMA), By Service Provider (In-house, Outsourcing), By Organisation Size (Small, Medium, Large), by Region, Country, Segment, and Companies, 2024-2030
... By Indication (Oncology, Neurology, Cardiology, Immunology, Others), By Product Stage (Preclinical, Clinical studies, PMA), By Service Provider (In-house, Outsourcing), By Organisation Size (Small, Medium, Large), by Region, Country, Segment, and Companies, 2024-2030 The global Pharmaceutical ... Read More
-
Microbial Fermentation Technology Market Size, Trends, Analysis, and Outlook By Application (Antibiotics, Probiotics Supplements, Monoclonal Antibodies, Recombinant Proteins, Biosimilars, Vaccines, Enzymes, Small Molecules, Others), By End-user (Bio-Pharmaceutical Companies, Contract Research Organizations (CROs), CMOs & CDMOs, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global Microbial Fermentation Technology market size is poised to register 6.62% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Medical Affairs Outsourcing Market Size, Trends, Analysis, and Outlook By Services (Medical Writing & Publishing, Medical Monitoring, Medical Science Liaisons (MSLs), Medical Information, Others), By End-User (Pharmaceutical, Biopharmaceutical, Medical Devices), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global Medical Affairs Outsourcing market size is poised to register 13.4% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
Generic Pharmaceuticals Market Size, Trends, Analysis, and Outlook By Type (Simple Generics, Specialty Generics, Biosimilar), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Generic Pharmaceuticals ... Read More
-
Biologics Contract Development and Manufacturing Organization Market Size, Trends, Analysis, and Outlook By Type (Mammalian, Microbial), By Product (Biologics, Biosimilars), by Region, Country, Segment, and Companies, 2024-2030
... market size is poised to register 8.33% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biologics Contract Development and Manufacturing Organization market ... Read More
-
Pharmaceutical Manufacturing Market Size, Trends, Analysis, and Outlook By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules)), By Drug Development (In-house, Outsource), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Route of Administration (Oral, Topical, Parenteral, Inhalations, Others), By Therapy Area (Cardiovascular Diseases, Pain, Diabetes, Cancer, Respiratory Diseases, Others), By Prescription (Prescription Medicines, Over-the-counter (OTC) Medicines), By Age group (Children & Adolescents, Adults, Geriatric), By Sales Channel (Retail, Non-retail), by Region, Country, Segment, and Companies, 2024-2030
... of Administration (Oral, Topical, Parenteral, Inhalations, Others), By Therapy Area (Cardiovascular Diseases, Pain, Diabetes, Cancer, Respiratory Diseases, Others), By Prescription (Prescription Medicines, Over-the-counter (OTC) Medicines), By Age group (Children & Adolescents, Adults, Geriatric), By Sales ... Read More
-
AAV Contract Development and Manufacturing Organizations Market Size, Trends, Analysis, and Outlook By Workflow (Upstream Processing, Downstream Processing), By Type (Adherent Culture, Suspension Culture), By Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical and Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global AAV Contract Development and Manufacturing Organizations market size is poised to register ... Read More
-
Upstream Bioprocessing Market Size, Trends, Analysis, and Outlook By Product (Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags & Containers, Others), By Workflow (Media Preparation, Cell Culture, Cell Separation), By Use Type, Multi-Use, Single-Use), By Mode (In-House, Outsourced), by Region, Country, Segment, and Companies, 2024-2030
... Mode (In-House, Outsourced), by Region, Country, Segment, and Companies, 2024-2030 The global Upstream Bioprocessing market size is poised to register 16.38% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Related Biologics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilars
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Upstream Bioprocessing
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Wound Biologics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Bioseparation Chromatography
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Third Party Logistics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilar Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
Research Assistance
